Diagnostic Performance Of 4D Dynamic LAFOV FDG-PET Acquisition for Differentiation of Residual Disease and Post-radiation Inflammation in Head Neck SCC Treated by Radiotherapy.

ConditionHead & Neck Squamous Cell Carcinoma

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity Hospital, Brest

About this trial

This multicenter prospective observational study will evaluate the value of dynamic FDG-PET LAFOV imaging during the initial therapeutic assessment of a head and neck cancer 3 months after completion of curative radiotherapy.

Eligibility criteria

Qualifiers

Adult patient ≥ 18 years of age

Presenting with head and neck squamous cell carcinoma

Completed curative treatment with external radiation therapy

Eligible for dynamic LAFOV FDG-PET scan for therapeutic evaluation at 3 months

Disqualifiers

Hypersensitivity to 18F-FDG or other excipients contained in the contrast agent

Pregnancy or breastfeeding

History of treated upper gastrointestinal tract cancer

Other histology

Trial design

Treatments tested in this trial

Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University Hospital, Brest

Lead sponsor

Source ClinicalTrials.gov